Synthetic Biology: Production of Novel Antibiotics - Eriko Takano

TL;DR

Synthetic biology can revolutionize antibiotic production to combat resistance.

Transcript

Hello, my name is Eriko Takano and I'm from the University of Manchester. And today, I'd like to speak to you about synthetic biology for the production of high-value chemicals. So as you all know, antibiotic resistance is a very big problem, and it's a worldwide problem. You can see here there's methicillin-resistant Staphylococcus aureus increasi... Read More

Key Insights

• Antibiotic resistance is a significant global issue, necessitating innovative methods to discover and produce new antibiotics.
• Actinomycetes, soil-dwelling bacteria, are natural antibiotic producers with diverse chemical structures, presenting opportunities for novel antibiotic discovery.
• Genome sequencing of microbes reveals numerous secondary metabolite gene clusters, many of which remain unexplored and could lead to new antibiotics.
• Synthetic biology offers a systematic, high-throughput approach to awaken dormant gene clusters, accelerating antibiotic discovery and production.
• Synthetic biology involves engineering life forms using design, build, test, and learn principles, merging engineering concepts with biology.
• Synthetic biology can create compounds not found in nature by redesigning enzyme specificity and assembling novel gene clusters.
• Tools like antiSMASH and multigene BLASt help identify and annotate gene clusters, facilitating the discovery of potential antibiotic pathways.
• Metabolomics serves as a crucial debugging tool to fine-tune engineered pathways, ensuring optimal antibiotic production in synthetic biology.

Questions & Answers

Q: What is the main challenge addressed by Eriko Takano's research?

Eriko Takano's research addresses the growing problem of antibiotic resistance, which poses a significant threat to global health. By developing synthetic biology techniques, her team aims to discover and produce novel antibiotics, providing new solutions to combat resistant bacterial strains that traditional antibiotics can no longer effectively treat.

Q: How does synthetic biology contribute to antibiotic production?

Synthetic biology contributes to antibiotic production by enabling the systematic design and assembly of novel genetic pathways. This approach allows researchers to awaken dormant gene clusters in microbes, creating new antibiotics with diverse chemical structures. By integrating engineering principles with biology, synthetic biology accelerates the discovery and optimization of antibiotic production, offering innovative solutions to address resistance.

Q: What role do actinomycetes play in antibiotic production?

Actinomycetes are gram-positive, soil-dwelling bacteria that naturally produce antibiotics. They exhibit diverse chemical structures, making them a valuable source for discovering new antibiotics. By genome sequencing actinomycetes, researchers can identify numerous secondary metabolite gene clusters, many of which remain untapped and hold the potential to produce novel antibiotics, addressing the challenge of increasing resistance.

Q: What tools has Takano's lab developed to aid in antibiotic discovery?

Takano's lab has developed several software tools to aid in antibiotic discovery, including antiSMASH and multigene BLASt. These tools help identify and annotate secondary metabolite gene clusters, facilitating the exploration of potential antibiotic pathways. Additionally, they employ metabolomics as a debugging tool to optimize and fine-tune engineered pathways, ensuring efficient antibiotic production.

Q: Why is synthetic biology considered a potential industrial revolution?

Synthetic biology is considered a potential industrial revolution because it offers unprecedented versatility in engineering new life forms. By merging design, build, test, and learn principles from engineering with biological systems, synthetic biology can create entirely new compounds and pathways. This innovation could transform industries, including pharmaceuticals, by providing novel solutions like new antibiotics to combat global challenges such as antibiotic resistance.

Q: How does synthetic biology enable the production of compounds not found in nature?

Synthetic biology enables the production of compounds not found in nature by redesigning enzyme specificity and assembling novel gene clusters. Researchers can manipulate genetic sequences, altering enzyme activity and creating new biosynthetic pathways. This approach allows the production of unique chemical structures, expanding the repertoire of available antibiotics and potentially offering new treatments for resistant bacterial infections.

Q: What is the significance of metabolomics in synthetic biology?

Metabolomics is significant in synthetic biology as it serves as a crucial debugging tool to optimize engineered pathways. By analyzing the metabolites produced in a cell, researchers can identify and address inefficiencies or imbalances in the biosynthetic process. This comprehensive view of cellular metabolism aids in fine-tuning pathways, ensuring that synthetic biology applications, like antibiotic production, are effective and efficient.

Q: What challenges exist in awakening dormant gene clusters for antibiotic production?

Awakening dormant gene clusters for antibiotic production is challenging due to the complexity and time-consuming nature of traditional genetic manipulation methods. Researchers must systematically identify and activate these clusters, often requiring high-throughput techniques to accelerate the process. Synthetic biology offers solutions by providing tools and methodologies to systematically explore and optimize these gene clusters, overcoming the limitations of conventional approaches.

Summary & Key Takeaways

• Antibiotic resistance is an escalating global challenge, prompting the need for novel antibiotics. Eriko Takano's research focuses on utilizing synthetic biology to discover and produce new antibiotics by exploring dormant gene clusters in microbes.

• Synthetic biology combines engineering principles with biology to systematically design, build, and test new pathways. This approach can potentially revolutionize antibiotic production by creating compounds previously unknown to nature.

• Takano's lab employs advanced software tools like antiSMASH and multigene BLASt to identify gene clusters, model pathways, and optimize antibiotic production. Metabolomics is used as a debugging tool to ensure efficient and effective outcomes.